Reaction of maize hybrids to Northern corn leaf blight and common rust, and chemical control of Northern corn leaf blight

• Autor(a) principal: Camera,Juliane Nicolodi
• Data de Publicação: 2019
• Outros Autores: Forcelini,Carlos Alberto, Koefender,Jana, Golle,Diego Pascoal, Schoffel,André, Deuner,Carolina Cardoso
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Arquivos do instituto biológico (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-16572019000100225
• topic: Puccinia sorghi; Exerohilum turcicum; fungicides; yield

ABSTRACT: Northern corn leaf blight (NCLB) and common rust are among the primary fungal diseases affecting maize production. This study aimed to evaluate the susceptibility of ten maize hybrids to NCLB and to common rust and to verify the efficiency of fungicides in the chemical control of Exserohilum turcicum. In the first experiment, hybrids Pioneer (30F53, P1630H, P2530), Monsanto (AG 8045, AG 9045), Dow AgroSciences (2A550, 2A106 and 2B587) and Syngenta (SYN7205 VIPTERA, SW 3949 TL) were used and in the experiment for effectiveness of fungicides in the control of NCLB. The efficiency of fungicides propiconazole, azoxystrobin, cyproconazole + azoxystrobin, prothioconazole + trifloxystrobin, benzovindiflupir + azoxystrobin, cyproconazole + azoxystrobin + mancozeb were tested in the Pioneer P1630H hybrid. In both experiments, the leaf disease severity (%), yield and the weight of one thousand seeds were evaluated. The experimental design was carried out in randomized blocks with four replicates. The hybrids SYN7205, P2530, SW 3949 TL, 2B587, AG 9045, 2A550, P1630H, 2A106 and AG 8025 showed the smallest areas under the common rust severity progress curve. Hybrids AG9045, 30F53, and 2A550 presented the smallest areas under the NCLB progress curve. Hybrids AG8025, 2B587, P1630H, AG9045, 2A106, 2A550, present the highest yields. The fungicides prothioconazole + trifloxystrobin present the highest chemical control efficiency for NCLB and the lowest area under the disease progress curve (AUDPC).